ESMC · Escalon Medical Corp
Market Cap
$1.26M
Shares
7.42M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.18
Open$0.17
Day$0.17–0.18
52W close$0.12–0.35
Avg vol 30d9K
Short int83K · 1.1% float · 46.6d
Short vol15%
DataJan 2020–Sep 2026
Filing10-Q · May 15
Up next
FQ1-27 quarter ends
~Sep 30, 2026
Est
filed May 15, 2026
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Weak
Sentiment
Bullish
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 16.3 · calm
Equity put/call 0.67
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−24%
below
Price vs 50-day avg
−9%
below
RSI (14)
47
neutral
MACD trend
Negative
52-week position
24%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−8%
trailing
6-month return
−50%
trailing
YTD return
+3%
this year
Relative strength
−63%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Accumulating
+1 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
1.12% of float · ▼ -0.7% MoM · 46.6 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
1 holders — 13F breadth
Squeeze score
49
elevated · 0–100
Fundamentals
Revenue growth
−2%
Y/Y
EPS growth
+100%
Y/Y
Free cash flow
$376.8K
Quant / Vol
risk profile
Volatility
234%
annualized · 1-yr
Max drawdown
−74%
past year
ATR
7.3%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−24%
Bearish
Price vs 50-day avg
−9%
Bearish
RSI (14)
47
Neutral
MACD trend
Negative
Bearish
52-week position
24%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Accumulating
+1 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
1.12% of float · ▼ -0.7% MoM · 46.6 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
1 holders — 13F breadth
Price context
position in its 52-week range
Range low $0
Now $0 · 24%
Range high $0
vs 200-day avg -24%
vs 50-day avg -9%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ESMC
this stock
Escalon Medical Corp
|
$1.26M | +2.9% | -2.4% | — | 1.1% |
|
ABT
Abbott Laboratories
|
$191.81B | -13.1% | +5.7% | 30.9 | 1.2% |
|
SYK
Stryker Corp
|
$126.84B | -9.7% | +11.2% | 34.3 | 1.8% |
|
MDT
Medtronic plc
|
$116.78B | -4.2% | +8.4% | 24.5 | 1.1% |
|
BSX
Boston Scientific Corp
|
$70.00B | -49.6% | +12.5% | 19.6 | 1.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Accumulating
Holders
1
- % held
- 0.0%
- Net QoQ
- +1.3K sh
- Top holder
- VICTORY CAPITAL MANAGEMEN…
Held
Float
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ESMC | -2.8% | -7.9% | -50.0% | +6.1% | +2.9% |
| SPY | -0.5% | -1.2% | +12.6% | -0.7% | +11.7% |
| vs SPY | -2.2% | -6.7% | -62.6% | +6.8% | -8.8% |